Cetera Advisor Networks’s Takeda Pharmaceutical TAK Stock Holding History

Cetera Advisor Networks’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$231K	Buy	16,661 +2,006	+14%	+$29.2K	﹤0.01%	2485
2023 Q4	$209K	Buy	14,655 +1,210	+9%	+$17.2K	﹤0.01%	2513
2023 Q3	$208K	Buy	13,445 +76	+0.6%	+$1.18K	﹤0.01%	2402
2023 Q2	$210K	Sell	13,369 -653	-5%	-$10.7K	﹤0.01%	2324
2023 Q1	$231K	Buy	14,022 +1,967	+16%	+$31.3K	﹤0.01%	2226
2022 Q4	$188K	Buy	+12,055	New	+$168K	﹤0.01%	2278
2020 Q3	–	Sell	-6,204	Closed	-$111K	–	2826
2020 Q2	$111K	Buy	+6,204	New	+$111K	﹤0.01%	1443

Other funds holding TAK

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Cetera Advisor Networks's TAK Position: Q1 2024 in Review

Cetera Advisor Networks increased its Takeda Pharmaceutical (TAK) stake by 14% in Q1 2024, buying an estimated $29.2K and bringing the position to 16,661 shares worth $231K. The position accounts for ﹤0.01% of the portfolio, ranked #2485.

Cetera Advisor Networks first reported a position in TAK in Q2 2020 and has held it in 7 quarters since. 314 funds tracked by Wall St. Rank hold TAK as of Q1 2024.

Cetera Advisor Networks held 16,661 shares of Takeda Pharmaceutical worth $231K as of Q1 2024.
Cetera Advisor Networks bought 2,006 Takeda Pharmaceutical shares in Q1 2024, an estimated $29.2K.
Takeda Pharmaceutical made up ﹤0.01% of Cetera Advisor Networks's portfolio in Q1 2024, its #2485 holding.
Cetera Advisor Networks first reported a position in Takeda Pharmaceutical in Q2 2020 and has held it in 7 quarters since.
314 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q1 2024.

Based on Cetera Advisor Networks's 13F filing for Q1 2024, filed 15 May 2024.